

Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|10|19|1973-1991
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.10, Iss.19, 2003-10, pp. : 1973-1991
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


By Zimmer A. Atmaca-Abdel Aziz S. Gilbert M. Werner D. Noe C.R.
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 47, Iss. 2, 1999-03 ,pp. :






2'-Modified Oligonucleotides for Antisense Therapeutics
Current Topics in Medicinal Chemistry, Vol. 7, Iss. 7, 2007-04 ,pp. :